Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma

Eisai

Status: Completed

Conditions: Malignant Glioma

Treatments: Other: No intervention

Study type: Observational

Funder types: Industry

Identifiers

NCT02300506

GLI02T

Details and patient eligibility

About

The objective of this study is to determine the survival status of patients enrolled in study GLI01S (all-case observational study).

Enrollment: 507 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Malignant Glioma, patients enrolled in study GLI01S.

Exclusion criteria

• Corresponding to contraindication of Gliadel.
• Not applicable to indications of Gliadel.

Trial design

507 participants in 1 patient group

Cohort 1

Description:

Patients with diagnosed malignant glioma treated by surgery, implanted Gliadel wafers 7.7mg, and enrolled in study GLI01S.

Treatment:

Other: No intervention